Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2023-01-06

FDA Approved: BRIVARACETAM — Original Application (Aurobindo Pharma Limited)

View source ↗

Summary

FDA approved a generic version of brivaracetam from Aurobindo Pharma Limited under an Original Application (ANDA 214848).

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • BRIVARACETAM (brivaracetam)

Snippet

ORIG AP for BRIVARACETAM (BRIVARACETAM)